A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis - Langford, C A; Cuthbertson, D; Ytterberg, S R; Vasculitis Clinical Research Consortium (Arthritis Rheumatol, 2017)